{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2 main protease", "drug discovery", "marine natural products", "molecular docking", "molecular dynamics", "virtual drug screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33916461", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "05"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "05"}], "Language": ["eng"], "ELocationID": ["2082", "10.3390/molecules26072082"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "7", "PubDate": {"Year": "2021", "Month": "Apr", "Day": "05"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "In Silico Mining of Terpenes from Red-Sea Invertebrates for SARS-CoV-2 Main Protease (M<sup>pro</sup>) Inhibitors.", "Abstract": {"AbstractText": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent for the COVID-19 pandemic, which generated more than 1.82 million deaths in 2020 alone, in addition to 83.8 million infections. Currently, there is no antiviral medication to treat COVID-19. In the search for drug leads, marine-derived metabolites are reported here as prospective SARS-CoV-2 inhibitors. Two hundred and twenty-seven terpene natural products isolated from the biodiverse Red-Sea ecosystem were screened for inhibitor activity against the SARS-CoV-2 main protease (M<sup>pro</sup>) using molecular docking and molecular dynamics (MD) simulations combined with molecular mechanics/generalized Born surface area binding energy calculations. On the basis of <i>in silico</i> analyses, six terpenes demonstrated high potency as M<sup>pro</sup> inhibitors with \u0394<i>G</i><sub>binding</sub> \u2264 -40.0 kcal/mol. The stability and binding affinity of the most potent metabolite, erylosides B, were compared to the human immunodeficiency virus protease inhibitor, lopinavir. Erylosides B showed greater binding affinity towards SARS-CoV-2 M<sup>pro</sup> than lopinavir over 100 ns with \u0394<i>G</i><sub>binding</sub> values of -51.9 vs. -33.6 kcal/mol, respectively. Protein-protein interactions indicate that erylosides B biochemical signaling shares gene components that mediate severe acute respiratory syndrome diseases, including the cytokine- and immune-signaling components <i>BCL2L1</i>, <i>IL2</i>, and <i>PRKC</i>. Pathway enrichment analysis and Boolean network modeling were performed towards a deep dissection and mining of the erylosides B target-function interactions. The current study identifies erylosides B as a promising anti-COVID-19 drug lead that warrants further <i>in vitro</i> and <i>in vivo</i> testing."]}, "AuthorList": [{"Identifier": ["0000-0003-4819-2040"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}], "LastName": "Ibrahim", "ForeName": "Mahmoud A A", "Initials": "MAA"}, {"Identifier": ["0000-0003-3527-0126"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}], "LastName": "Abdelrahman", "ForeName": "Alaa H M", "Initials": "AHM"}, {"Identifier": ["0000-0003-1639-3518"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt."}], "LastName": "Mohamed", "ForeName": "Tarik A", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Molecular Genetics and Genome Mapping Laboratory, Genome Mapping Department, Agricultural Genetic Engineering Research Institute (AGERI), Agricultural Research Center (ARC), Giza 12619, Egypt."}], "LastName": "Atia", "ForeName": "Mohamed A M", "Initials": "MAM"}, {"Identifier": ["0000-0003-2462-1269"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Oceanography & Fisheries, NIOF, Cairo 11516, Egypt."}], "LastName": "Al-Hammady", "ForeName": "Montaser A M", "Initials": "MAM"}, {"Identifier": ["0000-0001-8667-664X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt."}], "LastName": "Abdeljawaad", "ForeName": "Khlood A A", "Initials": "KAA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "National Institute of Oceanography & Fisheries, NIOF, Cairo 11516, Egypt."}], "LastName": "Elkady", "ForeName": "Eman M", "Initials": "EM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, King Khalid University, Abha 9004, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Botany & Microbiology, Faculty of Science, South Valley University, Qena 83523, Egypt."}], "LastName": "Moustafa", "ForeName": "Mahmoud F", "Initials": "MF"}, {"Identifier": ["0000-0002-0850-5500"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Alrumaihi", "ForeName": "Faris", "Initials": "F"}, {"Identifier": ["0000-0002-6486-9835"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia."}], "LastName": "Allemailem", "ForeName": "Khaled S", "Initials": "KS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, S-106 91 Stockholm, Sweden."}, {"Identifier": [], "Affiliation": "Department of Chemistry, Faculty of Science, El-Menoufia University, Shebin El-Kom 32512, Egypt."}, {"Identifier": [], "Affiliation": "International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China."}], "LastName": "El-Seedi", "ForeName": "Hesham R", "Initials": "HR"}, {"Identifier": ["0000-0003-1644-723X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry & Biochemistry, Texas Tech University, Lubbock, TX 79409, USA."}], "LastName": "Par\u00e9", "ForeName": "Paul W", "Initials": "PW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Efferth", "ForeName": "Thomas", "Initials": "T"}, {"Identifier": ["0000-0002-0343-4969"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt."}, {"Identifier": [], "Affiliation": "Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany."}], "LastName": "Hegazy", "ForeName": "Mohamed-Elamir F", "Initials": "MF"}], "GrantList": [{"GrantID": "5480", "Agency": "Science and Technology Development Fund", "Country": ""}, {"GrantID": "7972", "Agency": "Science and Technology Development Fund", "Country": ""}, {"GrantID": "143/42", "Agency": "King Khalid University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Matrix Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "membrane protein, SARS-CoV-2"}, {"RegistryNumber": "2494G1JF75", "NameOfSubstance": "Lopinavir"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["virology"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hydrogen Bonding"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Invertebrates"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Lopinavir"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["chemistry", "isolation & purification", "therapeutic use"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["isolation & purification", "metabolism"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["chemistry", "isolation & purification", "metabolism", "therapeutic use"], "DescriptorName": "Terpenes"}, {"QualifierName": [], "DescriptorName": "Thermodynamics"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Viral Matrix Proteins"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Vicenzi E., Canducci F., Pinna D., Mancini N., Carletti S., Lazzarin A., Bordignon C., Poli G., Clementi M. Coronaviridae and SARS-associated coronavirus strain HSR1. Emerg. Infect. Dis. 2004;10:413\u2013418. doi: 10.3201/eid1003.030683.", "ArticleIdList": ["10.3201/eid1003.030683", "PMC3322807", "15109406"]}, {"Citation": "Peng Q., Peng R., Yuan B., Zhao J., Wang M., Wang X., Wang Q., Sun Y., Fan Z., Qi J., et al. Structural and biochemical characterization of the nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2. Cell Rep. 2020;31:107774\u2013107788. doi: 10.1016/j.celrep.2020.107774.", "ArticleIdList": ["10.1016/j.celrep.2020.107774", "PMC7260489", "32531208"]}, {"Citation": "Harapan H., Itoh N., Yufika A., Winardi W., Keam S., Te H., Megawati D., Hayati Z., Wagner A.L., Mudatsir M. Coronavirus disease 2019 (COVID-19): A literature review. J. Infect. Public Health. 2020;13:667\u2013673. doi: 10.1016/j.jiph.2020.03.019.", "ArticleIdList": ["10.1016/j.jiph.2020.03.019", "PMC7142680", "32340833"]}, {"Citation": "Huang Y., Yang C., Xu X.F., Xu W., Liu S.W. Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19. Acta Pharm. Sin. 2020;41:1141\u20131149. doi: 10.1038/s41401-020-0485-4.", "ArticleIdList": ["10.1038/s41401-020-0485-4", "PMC7396720", "32747721"]}, {"Citation": "Dai L., Gao G.F. Viral targets for vaccines against COVID-19. Nat. Rev. Immunol. 2021;21:73\u201382. doi: 10.1038/s41577-020-00480-0.", "ArticleIdList": ["10.1038/s41577-020-00480-0", "PMC7747004", "33340022"]}, {"Citation": "Kemp S.A., Collier D.A., Datir R.P., Ferreira I., Gayed S., Jahun A., Hosmillo M., Rees-Spear C., Mlcochova P., Lumb I.U., et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021:1\u201310. doi: 10.1038/s41586-021-03291-y.", "ArticleIdList": ["10.1038/s41586-021-03291-y", "PMC7610568", "33545711"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science. 2020;368:409\u2013412. doi: 10.1126/science.abb3405.", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Kumar Y., Singh H., Patel C.N. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. J. Infect Public Health. 2020;13:1210\u20131223. doi: 10.1016/j.jiph.2020.06.016.", "ArticleIdList": ["10.1016/j.jiph.2020.06.016", "PMC7297718", "32561274"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Allemailem K.S., Almatroudi A., Moustafa M.F., Hegazy M.-E.F. In silico evaluation of prospective anti-COVID-19 drug candidates as potential SARS-CoV-2 main protease inhibitors. Protein J. 2021:1\u201314. doi: 10.1007/s10930-020-09945-6.", "ArticleIdList": ["10.1007/s10930-020-09945-6", "PMC7776322", "33387249"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Hussien T.A., Badr E.A.A., Mohamed T.A., El-Seedi H.R., Pare P.W., Efferth T., Hegazy M.F. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Comput. Biol. Med. 2020;126:104046\u2013104055. doi: 10.1016/j.compbiomed.2020.104046.", "ArticleIdList": ["10.1016/j.compbiomed.2020.104046", "PMC7543985", "33065388"]}, {"Citation": "Ibrahim M.A.A., Abdelrahman A.H.M., Hegazy M.F. In-silico drug repurposing and molecular dynamics puzzled out potential SARS-CoV-2 main protease inhibitors. J. Biomol. Struct. Dyn. 2020:1\u201312. doi: 10.1080/07391102.2020.1791958.", "ArticleIdList": ["10.1080/07391102.2020.1791958", "PMC7441803", "32684114"]}, {"Citation": "Ibrahim M.A.A., Abdeljawaad K.A.A., Abdelrahman A.H.M., Hegazy M.F. Natural-like products as potential SARS-CoV-2 M(pro) inhibitors: In-silico drug discovery. J. Biomol. Struct. Dyn. 2020:1\u201313. doi: 10.1080/07391102.2020.1790037.", "ArticleIdList": ["10.1080/07391102.2020.1790037", "PMC7443551", "32643529"]}, {"Citation": "Ibrahim M.A.A., Mohamed E.A.R., Abdelrahman A.H.M., Allemailem K.S., Moustafa M.F., Shawky A.M., Mahzari A., Hakami A.R., Abdeljawaad K.A.A., Atia M.A.M. Rutin and flavone analogs as prospective SARS-CoV-2 main protease inhibitors: In silico drug discovery study. J. Mol. Graph. Model. 2021:107904. doi: 10.1016/j.jmgm.2021.107904.", "ArticleIdList": ["10.1016/j.jmgm.2021.107904", "PMC7980232", "33798836"]}, {"Citation": "Zakaryan H., Arabyan E., Oo A., Zandi K. Flavonoids: Promising natural compounds against viral infections. Arch. Virol. 2017;162:2539\u20132551. doi: 10.1007/s00705-017-3417-y.", "ArticleIdList": ["10.1007/s00705-017-3417-y", "PMC7087220", "28547385"]}, {"Citation": "Cherrak S.A., Merzouk H., Mokhtari-Soulimane N. Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies. PLoS ONE. 2020;15:e0240653\u2013e0240666. doi: 10.1371/journal.pone.0240653.", "ArticleIdList": ["10.1371/journal.pone.0240653", "PMC7561147", "33057452"]}, {"Citation": "Jo S., Kim S., Kim D.Y., Kim M.-S., Shin D.H. Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J. Enzym. Inhib. Med. Chem. 2020;35:1539\u20131544. doi: 10.1080/14756366.2020.1801672.", "ArticleIdList": ["10.1080/14756366.2020.1801672", "PMC7470085", "32746637"]}, {"Citation": "Mayer A.M., Rodriguez A.D., Berlinck R.G., Hamann M.T. Marine pharmacology in 2003\u20134: Marine compounds with anthelmintic antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action. Comp. Biochem. Physiol. C Toxicol. Pharm. 2007;145:553\u2013581.", "ArticleIdList": ["PMC2151674", "17392033"]}, {"Citation": "Mayer A.M., Hamann M.T. Marine pharmacology in 2000: Marine compounds with antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiplatelet, antituberculosis, and antiviral activities; affecting the cardiovascular, immune, and nervous systems and other miscellaneous mechanisms of action. Mar. Biotechnol. 2004;6:37\u201352.", "ArticleIdList": ["PMC4934889", "14583811"]}, {"Citation": "Hegazy M.E., Mohamed T.A., Alhammady M.A., Shaheen A.M., Reda E.H., Elshamy A.I., Aziz M., Pare P.W. Molecular architecture and biomedical leads of terpenes from red sea marine invertebrates. Mar. Drugs. 2015;13:3154\u20133181. doi: 10.3390/md13053154.", "ArticleIdList": ["10.3390/md13053154", "PMC4446624", "26006713"]}, {"Citation": "Koop K., Booth D., Broadbent A., Brodie J., Bucher D., Capone D., Coll J., Dennison W., Erdmann M., Harrison P., et al. ENCORE: The effect of nutrient enrichment on coral reefs. Synthesis of results and conclusions. Mar. Pollut. Bull. 2001;42:91\u2013120. doi: 10.1016/S0025-326X(00)00181-8.", "ArticleIdList": ["10.1016/S0025-326X(00)00181-8", "11381890"]}, {"Citation": "Ayyad S.N., Alarif W.M., Al-Footy K.O., Selim E.A., Ghandourah M.A., Aly M.M., Alorfi H.S. Isolation, antimicrobial and antitumor activities of a new polyhydroxysteroid and a new diterpenoid from the soft coral Xenia umbellata. Z Nat. C J. Biosci. 2017;72:27\u201334. doi: 10.1515/znc-2015-0228.", "ArticleIdList": ["10.1515/znc-2015-0228", "27626764"]}, {"Citation": "Hegazy M.E., Gamal Eldeen A.M., Shahat A.A., Abdel-Latif F.F., Mohamed T.A., Whittlesey B.R., Pare P.W. Bioactive hydroperoxyl cembranoids from the Red Sea soft coral Sarcophyton glaucum. Mar. Drugs. 2012;10:209\u2013222. doi: 10.3390/md10010209.", "ArticleIdList": ["10.3390/md10010209", "PMC3280536", "22363231"]}, {"Citation": "Horby P.W., Mafham M., Bell J.L., Linsell L., Staplin N., Emberson J., Palfreeman A., Raw J., Elmahi E., Prudon B., et al. Lopinavir\u2013ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial. Lancet. 2020;396:1345\u20131352. doi: 10.1016/S0140-6736(20)32013-4.", "ArticleIdList": ["10.1016/S0140-6736(20)32013-4", "PMC7535623", "33031764"]}, {"Citation": "De Vivo M., Masetti M., Bottegoni G., Cavalli A. Role of molecular dynamics and related methods in drug discovery. J. Med. Chem. 2016;59:4035\u20134061. doi: 10.1021/acs.jmedchem.5b01684.", "ArticleIdList": ["10.1021/acs.jmedchem.5b01684", "26807648"]}, {"Citation": "Kerrigan J.E. Molecular dynamics simulations in drug design. In: Kortagere S., editor. In Silico Models for Drug Discovery. Humana Press; Totowa, NJ, USA: 2013. pp. 95\u2013113.", "ArticleIdList": ["10.1007/978-1-62703-342-8_7", "23568466"]}, {"Citation": "Noroozi R., Branicki W., Pyrc K., Labaj P.P., Pospiech E., Taheri M., Ghafouri-Fard S. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions. Cytokine. 2020;133:155143\u2013155147. doi: 10.1016/j.cyto.2020.155143.", "ArticleIdList": ["10.1016/j.cyto.2020.155143", "PMC7241386", "32460144"]}, {"Citation": "Zhou Y., Hou Y., Shen J., Huang Y., Martin W., Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discov. 2020;6:14. doi: 10.1038/s41421-020-0153-3.", "ArticleIdList": ["10.1038/s41421-020-0153-3", "PMC7073332", "32194980"]}, {"Citation": "Oldham W.M., Hamm H.E. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat. Rev. Mol. Cell Biol. 2008;9:60\u201371. doi: 10.1038/nrm2299.", "ArticleIdList": ["10.1038/nrm2299", "18043707"]}, {"Citation": "Birch C.A., Molinar-Inglis O., Trejo J. Subcellular hot spots of GPCR signaling promote vascular inflammation. Curr. Opin. Endocr. Metab. Res. 2021;16:37\u201342. doi: 10.1016/j.coemr.2020.07.011.", "ArticleIdList": ["10.1016/j.coemr.2020.07.011", "PMC7431397", "32838054"]}, {"Citation": "Hameid R.A., Cormet-Boyaka E., Kuebler W.M., Uddin M., Berdiev B.K. SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport. Am. J. Physiol. Lung Cell Mol. Physiol. 2021;320:L430\u2013L435. doi: 10.1152/ajplung.00499.2020.", "ArticleIdList": ["10.1152/ajplung.00499.2020", "PMC7938641", "33434105"]}, {"Citation": "Jin Z., Du X., Xu Y., Deng Y., Liu M., Zhao Y., Zhang B., Li X., Zhang L., Peng C., et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289\u2013293. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Gordon J.C., Myers J.B., Folta T., Shoja V., Heath L.S., Onufriev A. H++: A server for estimating pKas and adding missing hydrogens to macromolecules. Nucleic Acids Res. 2005;33:W368\u2013W371. doi: 10.1093/nar/gki464.", "ArticleIdList": ["10.1093/nar/gki464", "PMC1160225", "15980491"]}, {"Citation": "Hawkins P.C., Skillman A.G., Warren G.L., Ellingson B.A., Stahl M.T. Conformer generation with OMEGA: Algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J. Chem. Inf. Model. 2010;50:572\u2013584. doi: 10.1021/ci100031x.", "ArticleIdList": ["10.1021/ci100031x", "PMC2859685", "20235588"]}, {"Citation": "OMEGA 2.5.1.4. OpenEye Scientific Software; Santa Fe, NM, USA: 2013."}, {"Citation": "SZYBKI 1.9.0.3. OpenEye Scientific Software; Santa Fe, NM, USA: 2016."}, {"Citation": "Halgren T.A. MMFF VI. MMFF94s option for energy minimization studies. J. Comput. Chem. 1999;20:720\u2013729. doi: 10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X.", "ArticleIdList": ["10.1002/(SICI)1096-987X(199905)20:7<720::AID-JCC7>3.0.CO;2-X", "34376030"]}, {"Citation": "Morris G.M., Huey R., Lindstrom W., Sanner M.F., Belew R.K., Goodsell D.S., Olson A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Forli S., Huey R., Pique M.E., Sanner M.F., Goodsell D.S., Olson A.J. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat. Protoc. 2016;11:905\u2013919. doi: 10.1038/nprot.2016.051.", "ArticleIdList": ["10.1038/nprot.2016.051", "PMC4868550", "27077332"]}, {"Citation": "Gasteiger J., Marsili M. Iterative partial equalization of orbital electronegativity\u2014A rapid access to atomic charges. Tetrahedron. 1980;36:3219\u20133228. doi: 10.1016/0040-4020(80)80168-2.", "ArticleIdList": ["10.1016/0040-4020(80)80168-2"]}, {"Citation": "Case D.A., Betz R.M., Cerutti D.S., Cheatham T.E., Darden T.A., Duke R.E., Giese T.J., Gohlke H., Goetz A.W., Homeyer N., et al. AMBER 2016. University of California; San Francisco, CA, USA: 2016."}, {"Citation": "Maier J.A., Martinez C., Kasavajhala K., Wickstrom L., Hauser K.E., Simmerling C. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 2015;11:3696\u20133713. doi: 10.1021/acs.jctc.5b00255.", "ArticleIdList": ["10.1021/acs.jctc.5b00255", "PMC4821407", "26574453"]}, {"Citation": "Wang J., Wolf R.M., Caldwell J.W., Kollman P.A., Case D.A. Development and testing of a general amber force field. J. Comput. Chem. 2004;25:1157\u20131174. doi: 10.1002/jcc.20035.", "ArticleIdList": ["10.1002/jcc.20035", "15116359"]}, {"Citation": "Jakalian A., Jack D.B., Bayly C.I. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J. Comput. Chem. 2002;23:1623\u20131641. doi: 10.1002/jcc.10128.", "ArticleIdList": ["10.1002/jcc.10128", "12395429"]}, {"Citation": "Roux B., Simonson T. Implicit solvent models. Biophys Chem. 1999;78:1\u201320. doi: 10.1016/S0301-4622(98)00226-9.", "ArticleIdList": ["10.1016/S0301-4622(98)00226-9", "17030302"]}, {"Citation": "Bayly C.I., Cieplak P., Cornell W.D., Kollman P.A. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges\u2014The RESP model. J. Phys. Chem. 1993;97:10269\u201310280. doi: 10.1021/j100142a004.", "ArticleIdList": ["10.1021/j100142a004"]}, {"Citation": "Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., et al. Gaussian 09. Gaussian Inc.; Wallingford, CT, USA: 2009. Revision E01."}, {"Citation": "Darden T., York D., Pedersen L. Particle mesh Ewald: AnN\u22c5log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993;98:10089\u201310092. doi: 10.1063/1.464397.", "ArticleIdList": ["10.1063/1.464397"]}, {"Citation": "Berendsen H.J.C., Postma J.P.M., Vangunsteren W.F., Dinola A., Haak J.R. Molecular-dynamics with coupling to an external bath. J. Chem Phys. 1984;81:3684\u20133690. doi: 10.1063/1.448118.", "ArticleIdList": ["10.1063/1.448118"]}, {"Citation": "Miyamoto S., Kollman P.A. Settle\u2014An Analytical Version of the Shake and Rattle Algorithm for Rigid Water Models. J. Comput. Chem. 1992;13:952\u2013962. doi: 10.1002/jcc.540130805.", "ArticleIdList": ["10.1002/jcc.540130805"]}, {"Citation": "Dassault Syst\u00e8mes BIOVIA, B.D.S.V., Version 2019. Dassault Syst\u00e8mes BIOVIA; San Diego, CA, USA: 2019."}, {"Citation": "Massova I., Kollman P.A. Combined molecular mechanical and continuum solvent approach (MM-PBSA/GBSA) to predict ligand binding. Perspect Drug Discov. Des. 2000;18:113\u2013135. doi: 10.1023/A:1008763014207.", "ArticleIdList": ["10.1023/A:1008763014207"]}, {"Citation": "Onufriev A., Bashford D., Case D.A. Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins. 2004;55:383\u2013394. doi: 10.1002/prot.20033.", "ArticleIdList": ["10.1002/prot.20033", "15048829"]}, {"Citation": "Hou T., Wang J., Li Y., Wang W. Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking. J. Comput. Chem. 2011;32:866\u2013877. doi: 10.1002/jcc.21666.", "ArticleIdList": ["10.1002/jcc.21666", "PMC3043139", "20949517"]}, {"Citation": "Wang E., Sun H., Wang J., Wang Z., Liu H., Zhang J.Z.H., Hou T. End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design. Chem. Rev. 2019;119:9478\u20139508. doi: 10.1021/acs.chemrev.9b00055.", "ArticleIdList": ["10.1021/acs.chemrev.9b00055", "31244000"]}, {"Citation": "Heberle H., Meirelles G.V., da Silva F.R., Telles G.P., Minghim R. InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams. BMC Bioinform. 2015;16:169\u2013175. doi: 10.1186/s12859-015-0611-3.", "ArticleIdList": ["10.1186/s12859-015-0611-3", "PMC4455604", "25994840"]}, {"Citation": "Li R., Ma X., Song Y., Zhang Y., Xiong W., Li L., Zhou L. Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data. J. Cell Biochem. 2019;120:11265\u201311273. doi: 10.1002/jcb.28404.", "ArticleIdList": ["10.1002/jcb.28404", "30719773"]}, {"Citation": "Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., Amin N., Schwikowski B., Ideker T. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u20132504. doi: 10.1101/gr.1239303.", "ArticleIdList": ["10.1101/gr.1239303", "PMC403769", "14597658"]}, {"Citation": "Blucher A.S., McWeeney S.K., Stein L., Wu G. Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz. F1000Research. 2019;8:908. doi: 10.12688/f1000research.19592.1.", "ArticleIdList": ["10.12688/f1000research.19592.1", "PMC6644836", "31372215"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "3", "Day": "4"}, {"Year": "2021", "Month": "3", "Day": "25"}, {"Year": "2021", "Month": "3", "Day": "30"}, {"Year": "2021", "Month": "4", "Day": "30", "Hour": "1", "Minute": "3"}, {"Year": "2021", "Month": "5", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["33916461", "PMC8038614", "10.3390/molecules26072082", "molecules26072082"]}}], "PubmedBookArticle": []}